The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole.
A small (approximately 30) but varied group of organic and inorganic compounds appear to be carcinogenic in both humans and experimental animals. A much larger number and wider variety of chemical carcinogens, primarily synthetic organic compounds, are known for experimental animals. These agents include a small (approximately 30) and varied group of metabolites of green plants and fungi. Many more of these carcinogens must exist in the living world. As with the synthetic carcinogens, the majority of these naturally occurring carcinogens are procarcinogens that require metabolic conversion into reactive electrophilic and mutagenic ultimate carcinogens. These strong electrophiles combine covalently and non-enzymatically with nucleophilic sites in DNAs, RNAs, proteins, and small molecules in target tissues. One or more of the DNA adducts appear to initiate carcinogenesis in an irreversible manner. The subsequent promotion step leading to gross tumours may be completed by further administration of carcinogen or by treatment with non-carcinogenic promoters. Roles for the RNA and protein adducts in the carcinogenic process have not been excluded. Recent data on the metabolic activation and reactivity in vivo of the naturally occurring carcinogens ethyl carbamate and certain of the alkenylbenzene spice flavours are illustrative of these principles. These agents can initiate the carcinogenic process in male mouse liver with small doses given prior to weaning. Subsequent growth of the liver and male hormonal factors appear to function as promoters leading to gross hepatic tumors after one year. Reactive electrophilic metabolites of ethyl carbamate and of safrole and estragole and their nucleic acid adducts formed during initiation in mouse liver have been characterized.
D000225:Adenine / Q000031:analogs & derivatives / Q000378:metabolism; D000081248:Allylbenzene Derivatives; D000818:Animals; D000840:Anisoles / Q000009:adverse effects* / Q000378:metabolism; D001711:Biotransformation; D002274:Carcinogens, Environmental / Q000378:metabolism*; D006224:Cricetinae; D003562:Cytidine / Q000031:analogs & derivatives / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004149:Dioxoles / Q000009:adverse effects*; D005260:Female; D005421:Flavoring Agents / Q000009:adverse effects*; D006801:Humans; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000139:chemically induced; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced; D008297:Male; D051379:Mice; D012313:RNA / Q000378:metabolism; D051381:Rats; D012451:Safrole / Q000009:adverse effects* / Q000378:metabolism; D013997:Time Factors; D014520:Urethane / Q000009:adverse effects* / Q000378:metabolism
C012962:3,N(4)-ethenocytidine; D000081248:Allylbenzene Derivatives; D000840:Anisoles; D002274:Carcinogens, Environmental; D004149:Dioxoles; D005421:Flavoring Agents; C004981:1,N(6)-ethenoadenine; D014520:Urethane; D003562:Cytidine; D012313:RNA; D004247:DNA; C007633:estragole; D000225:Adenine; D012451:Safrole